Science and society Bridging the gap
Our health and that of our loved ones is important to us. It affects our daily lives, both physically and mentally. As research institutes of Radboudumc we believe that it is our task to increase knowledge through excellent scientific research, education and training and to share this knowledge with society. At Radboudumc we call this: having a significant impact on healthcare. These core tasks, together with high-quality specialist medical healthcare, are inextricably linked, thereby forming the core of our academic hospital.
Training researchers in medical sciences is of great importance for society, since those currently studying at Radboudumc will become the new generation of scientists, policymakers and entrepreneurs who will develop novel treatments and diagnostics and a better healthcare for today and tomorrow.
In the context of our mission our research aligns to the Dutch National Research Agenda. Scientists and clinicians are involved in obtaining a better understanding of disease diagnosis, prevention and treatment, as well as developing or improving healthcare guidelines.
Many of our researchers interact with patients and their relatives. Others work in close collaboration with public organizations (e.g. NWO, KNAW), companies/industry, schools, or regional government (province, Health Valley).
Research results are shared with the professional and lay community through contributions to guidelines and protocols, professional and lay publications, newspaper and broadcasting items, board membership of (inter)national public (societal) advisory groups and policy institutes, outreach activities and public-private collaborations.
The activities of the Department of Valorization includes the search for (inter)national research funding, support during grant application procedures, evaluation, patenting and commercialization of new technologies. We negotiate contracts and provide support in the creation of spin-off companies.read more
ParkinsonNet Example of the impact of our research
ParkinsonNet brings healthcare providers together and facilitates specialization, collaboration and the exchange of knowledge.read more
ParkinsonNet Example of the impact of our researchFifty thousand people in the Netherlands have Parkinson's disease. A number that will double by 2020. A multidisciplinary approach is needed to tackle this disease. That means that it is important for patients to be surrounded by well-trained healthcare professionals who work closely with the neurologist to optimally support the patient. With this in mind ParkinsonNet was established.
Scientific evaluations have shown that this approach is effective: ParkinsonNet offers higher quality care at lower costs. With the support of the Nijmegen team, one of the largest healthcare providers in the United States, Kaiser Permanente, has implemented a ParkinsonNet in California and ParkinsonNet has also been implemented by the Norwegian government.
Suketu Khandhar, movement disorder specialist at Kaiser Permanent: "ParkinsonNet defines the basic ingredients needed for a successful multidisciplinary treatment of people with Parkinson's disease with better results. Everyone knows that delicious apples are needed to make apple pie, but the best and most delicious apple pie can only be made if the top-notch ingredients are mixed together in the right way. For me, that is exactly what ParkinsonNet is about. I’m delighted to offer care in this way with Kaiser Permanente."
Cancer detection Example of the impact of our research
Radboudumc has developed a treatment that detects cancer much faster and less painfully. It’s the reason people from all over the world travel to Nijmegen.read more
Cancer detection Example of the impact of our researchIn the past, it could take years before cancer was detectable in the body. Only tumors of a certain size could be detected. This meant patients were often left in uncertainty for a long time. Now, by using harmless iron water, Prof. Dr. Jelle Barentsz, radiologist at the Radboudumc, can detect prostate cancer much faster and less painfully. For this reason, patients are willing to travel halfway across the world to Nijmegen to get treatment. Barentsz: “I want this treatment for all cancers, for all patients anywhere in the world, at an affordable cost, and all within seven years. And that’s going to happen!”
(video in Dutch)